- Home
- IMAB vs JSPR Comparison
IMAB vs JSPR Comparison
Compare IMAB & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- JSPR
- Stock Information
- Founded
- IMAB 2014
- JSPR 2018
- Country
- IMAB United States
- JSPR United States
- Employees
- IMAB N/A
- JSPR N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IMAB Health Care
- JSPR Health Care
- Exchange
- IMAB Nasdaq
- JSPR Nasdaq
- Market Cap
- IMAB 87.2M
- JSPR 82.7M
- IPO Year
- IMAB 2020
- JSPR N/A
- Fundamental
- Price
- IMAB $0.99
- JSPR $6.14
- Analyst Decision
- IMAB Strong Buy
- JSPR Strong Buy
- Analyst Count
- IMAB 3
- JSPR 11
- Target Price
- IMAB $8.00
- JSPR $67.75
- AVG Volume (30 Days)
- IMAB 270.7K
- JSPR 998.1K
- Earning Date
- IMAB 03-13-2025
- JSPR 03-03-2025
- Dividend Yield
- IMAB N/A
- JSPR N/A
- EPS Growth
- IMAB N/A
- JSPR N/A
- EPS
- IMAB N/A
- JSPR N/A
- Revenue
- IMAB $3,313,984.00
- JSPR N/A
- Revenue This Year
- IMAB N/A
- JSPR N/A
- Revenue Next Year
- IMAB N/A
- JSPR N/A
- P/E Ratio
- IMAB N/A
- JSPR N/A
- Revenue Growth
- IMAB N/A
- JSPR N/A
- 52 Week Low
- IMAB $0.84
- JSPR $5.25
- 52 Week High
- IMAB $2.00
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- IMAB 43.19
- JSPR 30.01
- Support Level
- IMAB $1.03
- JSPR $5.81
- Resistance Level
- IMAB $1.10
- JSPR $7.06
- Average True Range (ATR)
- IMAB 0.06
- JSPR 0.53
- MACD
- IMAB -0.01
- JSPR 0.60
- Stochastic Oscillator
- IMAB 7.58
- JSPR 40.26
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.